Buprenorphine Maintenance Dose Schedule and Treatment Setting - 2 - Tabular View

Tracking Information

First Received Date ^ICMJE

September 20, 1999

Last Updated Date

August 16, 2005

Start Date ^ICMJE

June 1996

Primary Completion Date

Current Primary Outcome Measures ^ICMJE

Depression
Withdrawal symptoms
Opioid and cocaine use
Social and psychological functioning
AIDS risk behavior
Opiate withdrawal symptoms

Original Primary Outcome Measures ^ICMJE

Same as current

Change History

Complete list of historical versions of study NCT00000319 on ClinicalTrials.gov Archive Site

Current Secondary Outcome Measures ^ICMJE

Original Secondary Outcome Measures ^ICMJE

Descriptive Information

Brief Title ^ICMJE

Buprenorphine Maintenance Dose Schedule and Treatment Setting - 2

Official Title ^ICMJE

Buprenorphine Maintenance Dose Schedule and Treatment Setting

Brief Summary

The purpose of this study is to evaluate the efficacy of treating opioid-dependent individuals with buprenorphine on a thrice-weekly schedule compared to daily dosing.

Detailed Description

Study Phase

Phase II

Study Type ^ICMJE

Interventional

Study Design ^ICMJE

Treatment

Condition ^ICMJE

Opioid-Related Disorders
Substance-Related Disorders

Intervention ^ICMJE

Drug: Buprenorphine

Study Arms / Comparison Groups

Publications *

* Includes publications given by the data provider as well as publications identified by National Clinical Trials Identifier (NCT ID) in Medline.

Recruitment Information

Recruitment Status ^ICMJE

Completed

Enrollment ^ICMJE

Completion Date

Primary Completion Date

Eligibility Criteria ^ICMJE

Please contact site for information.

Gender

Both

Ages

21 Years to 55 Years

Accepts Healthy Volunteers

Contacts ^ICMJE

Contact information is only displayed when the study is recruiting subjects

Location Countries ^ICMJE

United States

Administrative Information

NCT ID ^ICMJE

NCT00000319

Responsible Party

Study ID Numbers ^ICMJE

NIDA-09803-2, R01-09803-2

Study Sponsor ^ICMJE

National Institute on Drug Abuse (NIDA)

Collaborators ^ICMJE

Yale University

Investigators ^ICMJE

Principal Investigator:

Richard Schottenfeld, M.D.

Yale University

Information Provided By

National Institute on Drug Abuse (NIDA)

Verification Date

June 1996

^ICMJE Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP